Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

ITOS holding history

iTeos Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITOS overviewAll 13F holders of ITOSFull Q4 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ITOS by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,664,161−100.0%Sold outHolders
Q2 20251,664,161$16.6M<0.1%−62,297−3.6%ReducedHolders
Q1 20251,726,458$10.3M<0.1%+92,429+5.7%AddedHolders
Q4 20241,634,029$12.5M<0.1%−22,781−1.4%ReducedHolders
Q3 20241,656,810$16.9M<0.1%−393,196−19.2%ReducedHolders
Q2 20242,050,006$30.4M<0.1%+549,404+36.6%AddedHolders
Q1 20241,500,602$20.5M<0.1%+9,660+0.6%AddedHolders
Q4 20231,490,942$16.3M<0.1%−322,817−17.8%ReducedHolders
Q3 20231,813,759$19.9M<0.1%+40,407+2.3%AddedHolders
Q2 20231,773,352$23.5M<0.1%+3630.0%AddedHolders
Q1 20231,772,989$24.1M<0.1%−46,041−2.5%ReducedHolders
Q4 20221,819,030$35.5M<0.1%+67,930+3.9%AddedHolders
Q3 20221,751,100$33.4M<0.1%+121,514+7.5%AddedHolders
Q2 20221,629,586$33.6M<0.1%+153,544+10.4%AddedHolders
Q1 20221,476,042$47.5M<0.1%+415,232+39.1%AddedHolders
Q4 20211,060,810$49.4M<0.1%+441,779+71.4%AddedHolders
Q3 2021619,031$16.7M<0.1%+104,056+20.2%AddedHolders
Q2 2021514,975$13.2M<0.1%−178,776−25.8%ReducedHolders
Q1 2021693,751$23.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.